193 related articles for article (PubMed ID: 3468207)
1. Modulation in vitro and in vivo of ACNU resistance in a subline of C6 glioma with reserpine.
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y
J Neurosurg; 1987 Feb; 66(2):251-5. PubMed ID: 3468207
[TBL] [Abstract][Full Text] [Related]
2. [Overcoming of ACNU resistance in a subline of rat glioma in vitro and in vivo by reserpine].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2141-6. PubMed ID: 3459396
[TBL] [Abstract][Full Text] [Related]
3. [Enhanced effect of reserpine on growth-inhibitory action of ACNU on ACNU resistance C6 glioma].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3):464-6. PubMed ID: 6584086
[TBL] [Abstract][Full Text] [Related]
4. [Possibility of overcoming of ACNU resistance in an ACNU-resistant subline of C6 rat glioma].
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y
No To Shinkei; 1986 Nov; 38(11):1065-70. PubMed ID: 3468959
[TBL] [Abstract][Full Text] [Related]
5. Enhanced effect of reserpine upon growth-inhibitory action of ACNU on ACNU-resistant C6 glioma.
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
Br J Cancer; 1986 Jun; 53(6):773-7. PubMed ID: 3459511
[TBL] [Abstract][Full Text] [Related]
6. [Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor].
Yoshida T; Shimizu K; Hayakawa T; Mogami H; Sakamoto Y; Egawa T
No Shinkei Geka; 1987 Mar; 15(3):261-7. PubMed ID: 3474542
[TBL] [Abstract][Full Text] [Related]
7. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
Yoshida T; Ushio Y; Hayakawa T; Yamada K; Kato A; Mogami H; Nakata Y
No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
[TBL] [Abstract][Full Text] [Related]
8. The mechanism and overcoming of resistance in ACNU-resistant sublines of C6 and 9L rat glioma.
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
J Neurooncol; 1987; 5(3):195-203. PubMed ID: 3479534
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the mechanism of ACNU resistance in sublines of rat C6 glioma and 9L gliosarcoma in vitro].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Kato A; Mogami H; Sakamoto Y
No Shinkei Geka; 1986 Oct; 14(11):1299-304. PubMed ID: 3468375
[TBL] [Abstract][Full Text] [Related]
10. [Possibility of overcoming ACNU resistance in ACNU-resistant sublines of rat brain tumors in vitro by a calmodulin inhibitor].
Yoshida T; Shimizu K; Mogami H; Sakamoto Y; Egawa T
No Shinkei Geka; 1987 Feb; 15(2):143-9. PubMed ID: 3470626
[TBL] [Abstract][Full Text] [Related]
11. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y
Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
[TBL] [Abstract][Full Text] [Related]
12. Isolation and preliminary characterization of ACNU-resistant sublines of rat brain tumors in vivo.
Yoshida TK; Shimizu K; Koulousakis A; Sturm V; Beuls E
J Neurosurg; 1992 Sep; 77(3):451-6. PubMed ID: 1506893
[TBL] [Abstract][Full Text] [Related]
13. Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration.
Mineura K; Watanabe K; Izumi I; Kowada M
J Neurooncol; 1992 Nov; 14(3):201-5. PubMed ID: 1460484
[TBL] [Abstract][Full Text] [Related]
14. ACNU-resistant mutants of 9L rat glioma cell line. Isolation and preliminary characterization of these subclones.
Kokunai T; Tamaki N; Matsumoto S
J Neurosurg; 1985 Oct; 63(4):583-8. PubMed ID: 3861792
[TBL] [Abstract][Full Text] [Related]
15. [Enhancing effect of reserpine upon the cytotoxicity of ACNU on ACNU-resistant glioma cells].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
Neurol Med Chir (Tokyo); 1986 Dec; 26(12):925-30. PubMed ID: 2438568
[No Abstract] [Full Text] [Related]
16. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
Yoshida TK; Shimizu K; Koulousakis A; Sturm V
J Neurosurg; 1992 Nov; 77(5):778-82. PubMed ID: 1403122
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal chemotherapy with ACNU for meningeal gliomatosis.
Yoshida TK; Beuls E; Shimizu K; Koulousakis A; Sturm V
Br J Cancer; 1992 Dec; 66(6):999-1004. PubMed ID: 1457369
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells.
Nakagawa T; Kubota T; Ido K; Sakuma T; Matsuda K
J Neurooncol; 2006 Sep; 79(3):271-9. PubMed ID: 16645721
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) of glioma cells in vivo and in vitro.
Yoshida J; Shibuya N; Kobayashi T; Kageyama N
Cancer; 1982 Aug; 50(3):410-8. PubMed ID: 6953989
[TBL] [Abstract][Full Text] [Related]
20. Potential of O6-methylguanine or O6-benzylguanine in the enhancement of chloroethylnitrosourea cytotoxicity on brain tumours.
Mineura K; Izumi I; Watanabe K; Kowada M; Kohda K; Ikenaga M
Acta Neurochir (Wien); 1994; 128(1-4):13-20. PubMed ID: 7847129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
